Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4338 |
USP7/USP47 inhibitor
USP7/47 inhibitor-1 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP7/USP47 inhibitor (USP7/47 inhibitor-1) 是一种选择性泛素特异性蛋白酶 7/47 抑制剂,EC50值分别为 0.42 μM 和 1.0 μM。 | |||
T9217 |
USP7-IN-8
GNE-6776 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP7-IN-8 (GNE-6776) 是一种选择性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50 为 1.4 μM。它具有抗癌作用。 | |||
T13268 |
USP7-IN-1
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP7-IN-1 是泛素蛋白特异性蛋白酶的选择性、可逆性抑制剂,IC50为 77 μM,可用于癌症研究。 | |||
T13271 | USP7-IN-6 | DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP7-IN-6 is a potent inhibitor of ubiquitin-specific protease 7 (USP7, IC50: 6.8 nM). | |||
T13269 |
USP7-IN-3
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP7-IN-3 is a potent and selective allosteric inhibitor of ubiquitin-specific protease 7 (USP7). | |||
T69820 |
USP7-IN-4
|
||
USP7-IN-4 is a highly potent and selective allosteric USP7 inhibitor. | |||
T13270 | USP7-IN-5 | DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP7-IN-5 is a potent inhibitor of ubiquitin-specific protease 7 (USP7, IC50: 49.9 nM). | |||
T9122 |
XL177A
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
XL177A 是一种选择性不可逆的 USP7 抑制剂,IC50为 0.34 nM。它通过 p53 依赖性机制引发癌杀伤细胞作用。 | |||
T73234 | USP7-IN-7 | ||
USP7-IN-7 是一种 USP7抑制剂,IC50值 <10 nM。USP7-IN-7 对 p53 突变癌细胞株、p53 野生型血液肿瘤和神经母细胞瘤细胞株具有低纳摩尔值的细胞毒性。USP7-IN-7 可用于肿瘤研究。 | |||
T73136 |
USP7-IN-10
|
||
USP7-IN-10 是一种有效的泛素蛋白特异性蛋白酶 7USP7抑制剂,其 IC50为13.39 nM。 | |||
T73257 | USP7-IN-9 | ||
USP7-IN-9是一种高效USP7抑制剂,其IC50值为40.8 nM。该化合物可诱导RS4; 11 细胞发生(apoptosis),并使细胞周期在G0/G1及S期停滞。此外,USP7-IN-9能够降低癌症相关蛋白MDM2和DNMT1的表达量,同时增加抑癌蛋白p53与p21的表达量。 | |||
T79164 |
USP7-IN-12
|
||
USP7-IN-12(compound 1)是一种口服活性的有效Usp7抑制剂,其IC50为3.67 nM,并表现出抗增殖活性。 | |||
T78150 |
USP7-IN-10 hydrochloride
|
||
USP7-IN-10 hydrochloride (compound 1)是一种高效USP7抑制剂,具有13.39 nM的IC50值。 | |||
T69819 |
ALM2
|
||
ALM2 is an USP7 inhibitor. | |||
T15464 |
HBX 19818
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
HBX 19818 是一种特异性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50值为 28.1 μM。 | |||
T2424 |
P 22077
P22077 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
P 22077 (P22077) 是泛素蛋白特异性蛋白酶 USP7 抑制剂,EC50值为 8.6 μM,还可抑制 USP47,EC50值为 8.74 μM。 | |||
T15351 |
FT827
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
FT827 是选择性泛素特异性蛋白酶 7(USP7)共价抑制剂(Ki=4.2 µM,Kd=7.8 μM),靶向 USP7 的自抑制载脂蛋白形式的催化中心,可用于研究癌症。 | |||
T5461 |
GNE-6640
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
GNE 6640 是一种选择性泛素特异性肽酶 7(USP7)的非共价抑制剂,其对全长USP7、USP7 催化结构域、全长USP43 以及 Ub-MDM2 的IC50值分别为 0.75 μM、0.43 μM、20.3 μM 和 0.23 μM。 | |||
T6925 |
P005091
P5091 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
P005091 (P5091) 是一种选择性有效的泛素特异性蛋白酶7(USP7)抑制剂,EC50值为 4.2 μM。 | |||
T21527 |
HBX 41108
HBX-41108,7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 |
DUB; p53 | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
HBX 41108 (HBX-41108) 是一种泛素特异性蛋白酶 7 的非竞争性抑制剂,IC50为 424 nM。它诱导 p53 依赖的凋亡,抑制 USP7 介导的 p53 去泛素化以稳定 p53 并抑制癌细胞生长。 | |||
T3951 |
NSC632839
F6,Ubiquitin Isopeptidase Inhibitor II |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
NSC-632839 (Ubiquitin Isopeptidase Inhibitor II) 是一种非选择性异肽酶抑制剂,可抑制USP2、USP7和SENP2,EC50分别为 45±4 μM、37±1 μM 和 9.8±1.8 μM。 | |||
T4634 |
GNE-6776
GEN6776 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
GNE-6776 是一种具有口服活性的选择性USP7抑制剂。 | |||
T28284 |
P22074
P-22074 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
P22074是一种USP7抑制剂。它不像其卤代相关化合物那样是一种活跃的拮抗剂。P22074 具有抗肿瘤活性。 | |||
T1902 |
BAY 11-7082
BAY 11-7821 |
Apoptosis; Others; IκB/IKK; DUB; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; NF-κB; Others; Ubiquitination |
BAY 11-7082 (BAY 11-7821) 是一种 NF-κB 抑制剂,可抑制 TNFα 诱导的 IκBα 磷酸化 (IC50=10 μM)。BAY 11-7082 也是一种泛素特异性蛋白酶 USP7 和 USP21 的抑制剂 (IC50=0.19/0.96 μM)。 | |||
T67876 |
USP8-IN-2
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP8-IN-2 是一种有效的去泛素化酶 USP7和USP8 抑制剂,对USP8D 的IC50为4.0 μM。USP8-IN-2是治疗癌症和病毒感染的潜在化合物。 | |||
T67873 |
USP8-IN-3
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP8-IN-3 是一种有效的去泛素化酶 USP7和USP8 抑制剂,对USP8D 的IC50为4.0 μM。USP8-IN-3 对GH3 和 H1957 细胞的增殖有抑制作用,GI50 分别为 37.03 μM 和 6.01 μM。USP8-IN-3是治疗癌症和病毒感染的潜在化合物。 | |||
T74794 |
USP28-IN-4
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP28-IN-4 是一种高效的 USP28 抑制剂,对 USP28 的 IC50 值为 0.04 μM。USP28-IN-4 具有抗癌活性,抑制 USP2、USP7、USP8、USP9x、UCHL3和UCHL5。USP28-IN-4 对人结直肠癌和肺鳞癌细胞具有细胞毒性,通过泛素-蛋白酶体系统对c-Myc的细胞水平进行剂量依赖性下调。 | |||
T74793 |
USP28-IN-3
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP28-IN-3是一种高选择性 USP28 抑制剂,对USP28的IC50 值为 0.1 μM。USP28-IN-3 具有抗癌活性,抑制 USP2、USP7、USP8、USP9x、UCHL3和UCHL5。USP28-IN-3 对人结直肠癌和肺鳞癌细胞具有细胞毒性,通过泛素-蛋白酶体系统对c-Myc的细胞水平进行剂量依赖性下调。 | |||
T1862 |
PR-619
PR 619,2,6-Diamino-3,5-dithiocyanopyridine |
Apoptosis; DUB; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
PR-619 (2,6-Diamino-3,5-dithiocyanopyridine) 是一种 DUB 抑制剂,可诱导内质网应激和内质网应激相关的凋亡,对 USP4、USP8、USP7、USP2和 USP5的 EC50分别为 3.93、4.9、6.86、7.2 和 8.61 μM。 | |||
T12621L |
FT671
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
FT671 is a non-covalent and selective inhibitor of USP7 (IC50: 52 nM) It also binds to the USP7 catalytic domain (Kd: 65 nM). | |||
T24129 |
HBX28258
HBX 28258,HBX-28258 |
||
HBX28258 is a recombinant human USP7 protein inhibitor. In human colon cancer and embryonic kidney cell, it acts by binding the active site through a covalent mechanism and selectively inactivating USP7 protein. | |||
T22635 |
C598-0466
|
Others | Others |
USP7 inhibitor | |||
T69690 |
XL-188
|
||
XL-188 is a highly potent and selective inhibitor of USP7. XL188 inhibited USP7 catalytic domain and full-length enzyme with IC50 values of 193 and 90 nM, respectively. XL188 Promotes USP7-Dependent Loss of HDM2 and Increase of p53 and p21. XL188 represents one of only a small set of mammalian DUB inhibitors with low nanomolar potency and a high degree of selectivity relative to other DUBs | |||
T28546 |
RMPI-8226-38
RMPI 8226-38,RMPI-8226 38,RMPI8226-38,RMPI8226 38 |
||
RMPI-8226-38 is an irreversible inhibitor of USP7 with IC50 value of 22 uM against RMPI-8226. | |||
T12621 |
(R)-FT671
|
Others | Others |
(R)-FT671 is the R-isomer of FT671. FT671 is a potent, non-covalent and selective inhibitor of USP7 (IC50 of 52 nM) | |||
T71837 |
HBX
|
||
HBX is a deubiquitinase inhibitor. It inhibits HAdV type 5 (species C, HAdV-C5) replication and oncogenic transformation through inhibition of the cellular pro-viral factor ubiquitin-specific protease 7 (USP7). HBX also significantly inhibits virus genome replication and progeny release of all adenovirus types tested, with the exception of types 12 and 31, from tested species. | |||
T74792 | USP28-IN-2 | ||
USP28-IN-2是一种高选择性的USP28抑制剂(IC50=0.3 μM),能够特异性作用于USP2、USP7、USP8、USP9x、UCHL3 和 UCHL5。在体外实验中,USP28-IN-2对癌细胞表现出细胞毒性,作用机制为通过泛素-蛋白酶体途径降低c-Myc蛋白水平,并能减少Ankyrase-1/2的表达。此外,USP28-IN-2能增强结直肠癌细胞对药物瑞戈非尼的敏感性。 | |||
T74682 | U7D-1 | ||
U7D-1 是一种首创的、有效的和选择性的泛素特异性蛋白酶 7USP7PROTAC 降解剂,在 RS4;11 细胞中DC50为 33 nM。U7D-1 具有抗癌活性。U7D-1 可诱导 Jeko-1 细胞凋亡 (apoptosis)。 |